Shuttle Pharmaceuticals Holdings Inc (SHPH)
1.46
-0.16
(-9.88%)
USD |
NASDAQ |
Nov 05, 11:25
Shuttle Pharmaceuticals Holdings Research and Development Expense (Annual): 3.517M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.517M |
| December 31, 2022 | 1.047M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.022M |
| December 31, 2020 | 0.1618M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
0.1618M
Minimum
2020
3.517M
Maximum
2023
1.437M
Average
1.035M
Median
Research and Development Expense (Annual) Benchmarks
| Oragenics Inc | 15.49M |
| Soligenix Inc | 3.313M |
| Tonix Pharmaceuticals Holding Corp | 86.66M |
| Lixte Biotechnology Holdings Inc | 0.8981M |
| NovaBay Pharmaceuticals Inc | 0.068M |